Victoria Baltrus - 02 Jun 2026 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Reporting relationship: Chief Accounting Officer
Issuer ticker: OSCR
Reported as of: 02 Jun 2026
Net transaction value: -$33,417
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:17:07 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Melissa Curtin, Attorney-in-fact

Key filing fact

Victoria Baltrus filed Form 4 for Oscar Health, Inc. (OSCR) on 04 Jun 2026.

Key facts

This page summarizes Victoria Baltrus's Form 4 filing for Oscar Health, Inc. (OSCR).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 16:17.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: -$33,417.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001911946 Primary reporting owner

Baltrus Victoria

Relationship: Chief Accounting Officer
Address: 75 VARICK STREET, 5TH FLOOR, NEW YORK
Signature: /s/ Melissa Curtin, Attorney-in-fact
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSCR transaction

Class A Common Stock

Sale

Transaction value: $23,718
Shares: -1,091
Change %: -0.5%
Price: $21.74
Shares after: 215,021
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F3

OSCR transaction

Class A Common Stock

Sale

Transaction value: $9,698
Shares: -432
Change %: -0.2%
Price: $22.45
Shares after: 214,589
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Footnote F3

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.